Here, we report 9 out of 24 patients with non-contributory family history, harboring germline heterozygous deleterious mutation in well-known cancer predisposing genes (CHEK2, RAD51C, BRCA2, FANCA, RET, FH, and BAP1). Here, BRCA2 is linked to cancer.